Reem Mustafa, MD
Nephrology · Kansas City, KSNPI 1659504009
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $934 of the $1,069 with a category attached, or 87.4%. Every reported general payment came from a single manufacturer, Boehringer Ingelheim International GmbH. That places this record below the midpoint for nephrology clinicians in KS, where the typical reported total is $931.
Across 6 payments — averaging $178.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$1K
Across 57 payments — averaging $9958.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$311K
- Boehringer Ingelheim Pharma GmbH & Co.kg$256K
What the payments were for
- Travel & lodging$93487%
- Food & beverage$13513%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 6 | $1,069 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$934
How this compares
$1,069 in reported general payments places this provider in the 50th percentile of 55 nephrology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 14 | $2,251 |
| Lisinopril | 34 | $231 |
| Furosemide | 17 | $86 |
| Amlodipine Besylate | 19 | $51 |
| Hydrochlorothiazide | 22 | $48 |
| Carvedilol | 12 | $41 |
| Losartan Potassium | 12 | $37 |
| Metoprolol Succinate | 12 | $9 |
| Spironolactone | 12 | $8 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Kansas City
- Aditi GuptaKansas City$16K
- Alan YuKansas City$16K
- Ahmad TuffahaKansas City$15K
- Diane CibrikKansas City$12K
- Duncan JohnstoneKansas City$4K
- Amna IlaheKansas City$2K
- Sri YarlagaddaKansas City$1K
- Itunu OwoyemiKansas City$931
- Andrew StingoKansas City$637
- Venu NairKansas City$436
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.